According to the optimal cutoff value of SLC1A5 relative expression (4.039), 177 PAAD patients from the TCGA cohort were divided into high- and low-SLC1A5-expression groups (Supplementary Figure 1). Here, SLC1A5 is linked to pancreatic adenocarcinoma.